| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 45.8093 | 31 |
| GSM780708 | Untreated after 4 days (C2_1) | 46.9184 | 36 |
| GSM780709 | Untreated after 4 days (C3_1) | 45.6646 | 30 |
| GSM780719 | Untreated after 4 days (C1_2) | 45.4522 | 29 |
| GSM780720 | Untreated after 4 days (C2_2) | 44.3396 | 24 |
| GSM780721 | Untreated after 4 days (C3_2) | 39.8118 | 6 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 47.1455 | 37 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 48.8115 | 44 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 44.3473 | 24 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 44.7086 | 26 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 46.1277 | 33 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 43.4046 | 19 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 48.0292 | 41 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 41.6606 | 12 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 44.4059 | 24 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 44.7412 | 26 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 41.8557 | 13 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 44.9272 | 27 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 54.9442 | 59 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 47.6688 | 40 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 46.6985 | 35 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 46.9022 | 36 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 47.3864 | 38 |